Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/27/14 → 01/24/17 |
Funding
- VentiRx Pharmaceuticals Incorporated: $18,032.00
A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination with YTX-2337 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Keresztes, Roger (PI)
- Wu, Shenhong (CoPI)
- Kudelka, Andrzej (CoPI)
Project: Research